Clouds gather over Darktrace’s £3bn stock-exchange listing
Darktrace, the cybersecurity star, is planning to list on the London Stock Exchange. It is a promising company, but its top shareholder is in legal trouble. Matthew Partridge reports.
Deliveroo’s “disastrous” debut “damaged London’s reputation” for big tech flotations, says The Guardian. But now the City is about to receive a “shot in the arm”: cybersecurity firm Darktrace is planning a £3bn listing on the London Stock Exchange. Founded in 2013 by mathematicians from the University of Cambridge, artificial intelligence (AI) experts and cyberspecialists from GCHQ, Darktrace creates digital-security products that “self-learn and self-heal” to enable businesses to “stay one step ahead of hackers and viruses”. Darktrace has already secured a range of customers and has an advisory board that includes the former MI5 director-general Lord Evans of Weardale.
Unfortunately, it is also beset by fraud allegations against its founding shareholder Mike Lynch, say James Cook and Matthew Field in The Daily Telegraph. Darktrace has admitted that the negative publicity concerning criminal (in the US) and civil (in the UK) charges against Lynch, which stem from his time as CEO of Autonomy, could undermine the group’s reputation and share price. Lynch, who is fighting extradition to the US, denies any wrongdoing in both cases.
Too much for Goldman Sachs and UBS
The links between Lynch and Darktrace certainly run deep, says Graham Ruddick in The Times. As well as being a “key early backer” of Darktrace, Lynch and his wife own 18.5%, which could give the stock a nasty jolt if he is forced to sell his shares. There is even talk of potential liabilities from “possible money laundering offences” related to funding provided by Invoke Capital, the investment firm Lynch co-founded. Still, while the controversy was supposedly “too much for Goldman Sachs and UBS”, which reportedly declined to take part in the initial public offering (IPO), Darktrace believes the risk of being hit by any prosecution is “low”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Lynch’s legal woes are “hardly an ideal backdrop to a market debut”, says Helen Thomas in the Financial Times. But Darktrace “looks like the kind of tech listing the London market has actually been hoping for”. This is because it already has “more than 4,600 customers in more than 100 countries... up from about 1,600 in 2018” while its software is “quick to deploy”, meaning it can make sales by installing its system and letting it show its worth in a two or three-week trial. Such subscription contracts “mean predictable, recurring revenue”.
At the very least, Darktrace looks a lot more substantial than Deliveroo, says Simon English in the Evening Standard. For one thing, it is an “actual tech company, rather than a moped food service with an app on top”.
What’s more, “the share structure is a straight 1-1 on voting rights”, in contrast to Deliveroo’s dual-class system that many saw as “plainly unfair”. The size of the market has been estimated at $40bn, with Darktrace already making “a small profit” according to several accounting measures, compared with Deliveroo’s losses.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Water companies blocked from using customer money to pay “undeserved” bonuses
The regulator has blocked three water companies from using billpayer money to pay £1.5 million in exec bonuses
By Katie Williams Published
-
Will the Bitcoin price hit $100,000?
With Bitcoin prices trading just below $100,000, we explore whether the cryptocurrency can hit the milestone.
By Dan McEvoy Published
-
BT cuts annual revenue forecast – what's next for the telecoms giant?
BT has trimmed its sales forecast, but the overall outlook remains positive and big investors have bought in. Should you invest?
By Dr Matthew Partridge Published
-
Investing in a dangerous world: key takeaways from the MoneyWeek Summit
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published
-
How investors can use options to navigate a turbulent world
Explainer Options can be a useful solution for investors to protect and grow their wealth in volatile times.
By James Proudlock Published
-
Invest in Hilton Foods: a tasty UK food supplier
Hilton Foods is a keenly priced opportunity in an unglamorous sector
By Dr Matthew Partridge Published
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
By Dr Matthew Partridge Published
-
Lock in an 11% yield with Sabre
Tips Sabre, a best-in-class company is undervalued due to low profits in the motor insurance industry. Should you invest?
By Rupert Hargreaves Published
-
James Halstead is a family firm going cheap but should you buy?
James Halstead will rebound from a weak patch, while tax changes would be a buying opportunity
By Jamie Ward Published